Youmanitarian 11 Jun 2021

التالي

تشغيل تلقائي

Testosterone & Testosterone Replacement Therapy (TRT) | Dr. Peter Attia & Dr. Andrew Huberma

uchetex · 16 المشاهدات

PARP Inhibitors for Maintenance Therapy in Ovarian Cancer

0

0

18 المشاهدات

TAKE ACTION

Donations would go to support charities for كيف تصمم

في كيف تصمم

PARP, or poly-ADP ribose polymerase, inhibitors block repair of damaged DNA in tumor cells which increases cell death, especially in tumors with deficient repair mechanisms. One of the most recent important advances ovarian cancer treatment, PARP inhibitors have improved progression-free survival and are now being approved for first-line maintenance therapy in advanced stage disease. Several additional large-scale trials are underway with PARP inhibitors set to make great strides in improving outcomes in cancer therapy.

أظهر المزيد

More ways to take action

Explore ways that you can help bring a solution to this issue.

Create Youms with
hashtags كيف تصمم

Create a challenge to
bring awareness to this issue for people to complete

Create a fundraiser to
support a charity that tackle this issue

Volunteer at charitable organization
that support this cause

Create a movement page dedicated to this cause to bring awareness.

Start a uCharity for this cause and invite people to join it to support this cause

التالي

تشغيل تلقائي

Testosterone & Testosterone Replacement Therapy (TRT) | Dr. Peter Attia & Dr. Andrew Huberma

uchetex · 16 المشاهدات

الصفحة الرئيسية

الاقسام